Ketamine's brain impact revealed in small stanford study
NCT ID NCT03475277
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Stanford study looked at how ketamine changes activity in brain areas linked to reward and risk. Thirteen healthy adults who had used ketamine before underwent brain scans while performing tasks. The goal was to understand ketamine's effects on brain circuits, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ketamine
- What this could lead to
- If successful, this could help explain how ketamine alters brain reward pathways, potentially guiding future treatments for addiction or mood disorders.
- What could go wrong
- This is a very small, early biomarker study with only 13 healthy participants, so results may not apply to broader populations or lead directly to treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford Psychiatry
Palo Alto, California, 94304, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test